Non-coding RNAs as emerging biomarkers in melanoma

Key Points

• Non-coding RNAs act as emerging biomarkers in melanoma, enhancing diagnosis and prognosis.
• Significant correlations were identified between non-coding RNA levels and tumor progression in melanoma patients.
• Observational analysis across multiple melanoma cases highlighted key non-coding RNAs linked to disease outcomes.
• This work suggests possible diagnostic advancements, although further validation in larger cohorts is necessary.